Achard-Thiers syndrome, also referred to as “diabetic bearded women syndrome”, is a condition characterised by excessive hair growth (hirsutism) and diabetes in postmenopausal individuals assigned female at birth (AFAB). It is a rare under-researched condition, which explains the lack of information in identifying and describing clinical symptoms. Moreover, the risk factors and ultimate cause of the disorder remains unknown. Achard-Thiers syndrome is a part of the wider spectrum of metabolic diseases, which are complex and multi-faceted, therefore understanding the clinical features of the disorder is important to avoid misdiagnosis.
Overview
Achard-Thiers was first described in 1921 by two French doctors: Dr Emile Charles Achard and Joseph Thiers. The alternative naming of diabetic bearded women syndrome is due to its two defining characteristics of causing excess hair and the presentation of type 2 diabetes. The syndrome is very rare and under researched, resulting in the exact incidence of disease being unknown, although one study notes a prevalence of 0.33% of Achard-Thiers within a population of diabetic people AFAB.1
The route cause and initial triggering of this syndrome is not known either, but several of the underlying mechanisms of disease have been established.
Underlying mechanisms of Achard-Thiers syndrome
There are two mechanisms that are affected in this disorder, including:
- Hormonal pathways
- Metabolic pathways
Hormonal pathways
A characteristic of Achard-Thiers syndrome is hyperandrogenism, which refers to high levels of androgens within the body. Androgens are a group of sex hormones, with the most abundant and primary androgen being testosterone. Testosterone has a role in both individuals assigned male at birth (AMAB) and AFAB which aids in the triggering of puberty for both sexes.
Individuals AMAB have higher levels of the hormone, allowing the regulation of AMAB characteristics of the body such as hair, muscle growth and testes formation. In individuals AFAB, testosterone is present at lower levels and balanced with the hormones (oestrogen and progesterone). It has involvement in reproductive changes and growth. Androgens are secreted by the sex organs and in smaller quantities by the adrenal gland. The overproduction and high levels of testosterone in AFAB can result in presentation of these primarily AMAB characteristics (virilization) such as increased face and body hair, changes in muscle mass and dysregulated menstrual cycle.
Metabolic pathways
Type 2 diabetes is the other clinical characteristic of Achard-Thiers syndrome. Diabetes describes the condition of high levels of glucose (sugar) within the bloodstream, referred to as hyperglycemia. In normal circumstances, glucose levels are tightly controlled by a variety of pancreatic secreted hormones, including insulin. Insulin’s role is to signal to the body when blood glucose levels are too high, and the body needs to start using it for energy, or storing it away for later.
Diabetes can be defined as Type 1 and Type 2:
- Type 1: A lifelong immune disorder where the body starts attacking its own cells that produce insulin, resulting in little to no insulin production
- Type 2: A reduction in insulin production or body becomes resistant to the effects of insulin
When the body becomes insulin resistant and the body is still hyperglycemic, it can often lead to hyperinsulinemia, which is high levels of insulin in the blood. This is due to the pancreas overcompensating to produce more insulin as it can detect the blood glucose levels is still high, but insulin resistance stops the insulin from working at normal safe levels.
Chronic hyperglycemia and hyperinsulinemia can lead to a number of dangerous complications, including:
- Nerve damage
- Vision problems or loss
- Hardening of the arteries
- High blood pressure
- Diabetic ketoacidosis
Often individuals AFAB with Achard-Thiers syndrome will be diagnosed with polycystic ovary syndrome (PCOS) earlier in life, in adulthood or even adolescence. Hyperandrogenism and insulin resistance are prominent features of both disorders, which present with similar symptoms.
Clinical features
Achard-Thiers syndrome is a combination of androgen overproduction and type 2 diabetes, therefore it is important to consider these factors and the symptoms of the disorder can be linked to either one of the mechanisms.
Symptoms caused by diabetes (insulin-resistance)
- Increased urination
- Feelings of extreme thirst
- Increased hunger
- Fatigue
- Blurred vision
- Urinary tract infections
- Weight loss
Symptoms caused by hyperandrogenism
- Excess body hair (hirsutism)
- Discolouration of skin (acanthosis nigricans)
- Exaggerated male characteristics (virilization) - deepened voice, muscle growth, baldness
- Acne
- Obesity
- High blood pressure
- Irregular menstruation
- Infertility2
The symptoms in individuals with Achard-Thiers syndrome is varied, however medical diagnosis requires the presence of type 2 diabetes and excessive body and facial hair growth, says expert pharmacologist Dr Hina Firdous.
Metabolic diseases are often broad and complex, for example, diabetes can be indicative of a variety of different disorders, therefore it is important to have a thorough and complete diagnostic process.
Diagnostic criteria
| Test Type | Process | Result | Indication |
| Clinical assessment | Evaluation of symptoms, family history, age and genetics | Evidence of family history of disease Symptoms of hirsutism, fatigue, hyperinsulinemia, weight changesPost-menopausal aged individuals AFAB | Either type 2 diabetes or hyperandrogenism |
| HbA1c test | Blood test measuring the amount of glucose in the blood over 2-3 month period by its level of bonding to haemoglobin | 6.5% or higher High HbA1c levels reflects high blood glucose levels and potential insulin resistance3 | Type 2 diabetes |
| Oral-glucose tolerance test (OGTT) | Patient undergoes overnight fast and later consumes a high glucose (75g) drink. Blood glucose test is conducted 2 hours later | Over 11.0mmol/L of glucose in the blood High blood glucose levels reflect the body's inability to respond to increased intake and shows potential insulin resistance. | Type 2 diabetes |
| Hormonal blood test | Blood test used to primarily measure the level of free testosterone in the blood. | Free androgen index (FAI) is the most commonly used measurement of androgens in the blood FAI should be greater than5 | Hyperandrogenism |
| Ultrasound | Imaging test that creates images of internal organs and tissues by use of sound waves | Reveal presence of ovarian cysts or tumours | Rule out other conditions |
| MRI | Magnetic resonance imaging using magnetic fields to create detailed images of internal organs, tissues and blood vessels | Reveal presence of abnormalities or tumours in adrenal glands4 | Rule out other conditions |
With the confirmation of type 2 diabetes and hyperandrogenism through these tests, in addition to the physical characteristics of excess body/facial hair in post-menopausal individuals AFAB, a diagnosis of Achard-Thiers can be made.
Treatment
Anti-androgens
Medications can be used to block the production or the effects that the excess androgens have on the body.
Spironolactone
Spironolactone is used to stop the production of a specific enzyme used in the production of testosterone. This helps reduce the total testosterone level present in the body. The most common use for this drug is as a treatment for hirsutism, with successes in as high as 95% of patients.5
Gonadotropin-releasing hormone (GnRH) agonist
A GnRH agonist is used to downregulate the production of androgens by disrupting their signalling mechanism. This allows the decrease of testosterone within the body.6
This drug has seen success in individuals AFAB with hyperandrogenism by overproduction in their ovaries, with evidence of improvement in virilization symptoms.7
Anti-diabetics
Metformin
Metformin has been used for both type 2 diabetes and endocrine disorders such as PCOS. This is due to its success in lowering blood-glucose levels, reducing insulin resistance and depletions in androgen production.8
Metformin has several complex methods in treating these disorders, but one of the most important is its inhibition of gluconeogenesis. The blocking of glucose production helps the body maintain a safe blood-glucose range. In addition, it has actions in increasing sensitivity to insulin, again allowing the body to utilise glucose in the muscle for use and signalling to reduce more glucose production.
Lifestyle changes
Type 2 diabetes that presents with minimal symptoms can sometimes be treated without medications. This may involve changes to lifestyle that are essential to your health. This includes:
- Lower fat, sugar and salt intake
- Having a healthy balanced breakfast avoids dips in blood sugar
- Preparing your meals allows planning of nutritional information to control intake
- Reducing alcohol intake as they are often high in sugar
- Daily exercise, typically 30 minutes a day
- Losing weight
- Stop smoking
Stress management
Stress has a negative effect on anyone’s body, but since diabetes can increase risks of other cardiovascular problems, it is important to keep stress in check. This can be managed by yoga, meditation and allowing yourself to take time away from stressful situations and allow relaxation.
Cosmetic changes
Some individuals AFAB may choose to treat only their symptoms, especially if they are milder, by either regular shaving, bleaching and waxing to remove excess hair or additional skincare treatments to maintain acne.
Summary
Achard-Thiers syndrome presents a unique combination of symptoms affecting post-menopausal individuals AFAB. Being able to recognise these metabolic features such as diabetes and signs of hyperandrogenism in the form of hirsutism, a quick and accurate diagnosis can be concluded. Effective treatment and lifestyle changes can have a big impact on patient health and well-being, with strategies allowing the condition to become more manageable. Due to the rarity of the disorder, continued research and awareness is necessary, to keep patients informed and increase the quality of care they can receive.
References
- Roshni V, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat. Indian Journal of Endocrinology and Metabolism [Internet]. 2013 Jul-Aug [cited 2024 Jul 15];17(4):659-664. Available from:https://journals.lww.com/indjem/pages/articleviewer.aspx?year=2013&issue=17040&article=00016&type=Fulltext
- Malaisse W, Lauvaux JP, Franckson JRM, Bastenie PA. Diabetes in Bearded Women (Achard-Thiers-Syndrome). A Clinical and Metabolic Study of 20 Cases. Diabetologia [Internet]. 1965 April [cited 2024 Jul 15];1(¾);155-161. Available from:https://link.springer.com/content/pdf/10.1007/BF01257906.pdf
- Önal ZE, Atasayan V, Gürbüz T, Hepkaya E, Nuhoğlu Ç. Association of glycosylated hemoglobin (Hba1c) levels with Iinsulin resistance in obese children. African Health Sciences [Internet]. 2014 Sep [cited 2024 Jul 15];14(3):533. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209635/
- Zaman A, Rothman MS. Postmenopausal hyperandrogenism: evaluation and treatment strategies. Endocrinology and metabolism clinics of North America [Internet]. 2021 Mar [cited 2024 Jul 15];50(1):97. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004339/
- Cumming DC, Yang JC, Rebar RW, Yen SSC. Treatment of hirsutism with spironolactone. JAMA [Internet]. 1982 Mar 5 [cited 2024 Jul 15];247(9):1295–8. Available from: https://doi.org/10.1001/jama.1982.03320340049034
- Van Poppel H, Abrahamsson P. Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer. Int J of Urology [Internet]. 2020 Oct [cited 2024 Jul 15];27(10):830–7. Available from: https://onlinelibrary.wiley.com/doi/10.1111/iju.14303
- Vollaard ES, Beek AP, Verburg FAJ, Roos A, Land JA. Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin. The Hournal of Clinical Endocrinology & Metabolism [Internet]. 2011 May [cited 2024 July 15];96(5):1197-1201. Available from; https://academic.oup.com/jcem/article/96/5/1197/2833196#
- Attia GM, Almouteri MM, Alnakhli FT, Attia GM, Almouteri M, Alnakhli F. Role of metformin in polycystic ovary syndrome (Pcos)-related infertility. Cureus [Internet]. 2023 Aug 31 [cited 2024 Jul 15];15(8). Available from: https://www.cureus.com/articles/167371-role-of-metformin-in-polycystic-ovary-syndrome-pcos-related-infertility

